<DOC>
	<DOCNO>NCT00036881</DOCNO>
	<brief_summary>RATIONALE : It yet know whether zinc sulfate effective preventing loss ability taste food cancer patient undergo radiation therapy head neck cancer . PURPOSE : Randomized phase III trial determine effectiveness zinc sulfate prevent loss sense taste patient undergo radiation therapy head neck cancer .</brief_summary>
	<brief_title>Zinc Sulfate Preventing Loss Sense Taste Patients Undergoing Radiation Therapy Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether zinc sulfate prolongs time onset altered taste patient head neck cancer undergo radiotherapy . - Determine whether drug decrease overall incidence alter taste patient . - Determine whether drug result few radiotherapy treatment interruption patient . - Assess quality life patient treated drug . - Determine toxic effect drug patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord plan radiotherapy dose ( le 6,000 cGy v least 6,000 cGy ) , estimate amount oral mucosa radiation field ( 60 % less vs 60 % ) , age ( 50 vs 50 ) , concurrent chemotherapy ( yes v ) , smoke ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral zinc sulfate 3 time daily begin first week radiotherapy . - Arm II : Patients receive oral placebo 3 time daily begin first week radiotherapy . Treatment arm continue daily 1 month radiotherapy absence unacceptable toxicity . Quality life assess baseline , weekly treatment , 1 , 2 , 3 , 6 month completion treatment . Patients follow 1 , 2 , 3 , 6 month completion treatment every 6 month 1 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Dysgeusia</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis head neck cancer No stage I laryngeal cancer Planned treatment least 2,000 cGy external beam radiotherapy least 30 % oral cavity PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 3 month Gastrointestinal : Able tolerate oral medication No known mechanical obstruction alimentary tract No malabsorption No intractable vomiting ( 5 episode per week ) Other : No known intolerance zinc sulfate No known , untreated oral thrush Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Surgery : No prior surgery include ablation removal olfactory component taste Other : No concurrent zinc supplement Concurrent standard multivitamin allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>